We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

No Link Between Breast Cancer and Oral Contraceptives

By HospiMedica staff writers
Posted on 01 Aug 2002
A large, multicenter study has found that women who took oral contraceptives at some time in their lives are no more likely to develop breast cancer between the ages of 35 and 64 than other women the same age. The study appeared in the June 27, 2002, issue of The New England Journal of Medicine.

Researchers interviewed more than 9,200 women between 35 and 64 in various parts of the United States. About half had been diagnosed with breast cancer, while the other half had not. Interviewers asked both groups questions about their use of oral contraceptives and other hormones as well as other health-related questions. They found that women who had used any type of oral contraception did not have a greater risk of developing breast cancer than women who had not used oral contraception. Oral contraceptive use among women with a family history of breast cancer was not associated with a significantly increased breast cancer risk, nor was the initiation of oral contraceptive use at a young age.

About 89% of US women born since 1945 have used oral contraceptives, and large numbers of them are now reaching the ages of greatest breast cancer risk. "We conducted this study to resolve the long-standing concern that oral contraceptive use might be associated with an increased risk of breast cancer late in life. Our study provides scientific evidence that there is no such association,” said Robert Spirtas, Dr.P.H., chief of the contraception and reproductive health branch of the US National Institute of Child Health and Human Development (NICHD), which sponsored the study.




Related Links:
NICHD

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
BiPAP Machine
Breath Smart Series
New
Catheters
Camino 1104B Series

Latest Patient Care News

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization